Reference
Becerra V, et al. Cost-effectiveness and public health benefit of secondary cardiovascular disease prevention from improved adherence using a polypill in the UK. BMJ Open : e007111, No. 5, 9 May 2015. Available from: URL: http://doi.org/10.1136/bmjopen-2014-00711
Rights and permissions
About this article
Cite this article
Secondary prevention post-MI with three-drug polypill cost effective. PharmacoEcon Outcomes News 731, 33 (2015). https://doi.org/10.1007/s40274-015-2262-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2262-z